Publisher Correction: Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations (Nature Communications, (2015), 6, 1, (7502), 10.1038/ncomms8502);Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations

Nature Communications

Volumn 6, Issue , 2015, Pages

  Hayes, M Geoffrey ^a,b   Urbanek, Margrit ^a   Ehrmann, David A ^c   Armstrong, Loren L ^a   Lee, Ji Young ^a   Sisk, Ryan ^a   Karaderi, Tugce ^d   Barber, Thomas M ^e   McCarthy, Mark I ^d,f,g   Franks, Stephen ^h   Lindgren, Cecilia M ^d,i   Welt, Corrine K ^j   Diamanti Kandarakis, Evanthia ^k   Panidis, Dimitrios ^l   Goodarzi, Mark O ^m   Azziz, Ricardo ⁿ   Zhang, Yi ^o   James, Roland G ^o   Olivier, Michael ^p   Kissebah, Ahmed H ^o   Stener Victorin, Elisabet ^q   Legro, Richard S ^r   Dunaif, Andrea ^a   Alvero, Ruben ^s   Barnhart, Huiman X ^t   Baker, Valerie ^u   Barnhart, Kurt T ^v   Bates, G Wright ^w   Brzyski, Robert G ^x   Carr, Bruce R ^y   Carson, Sandra A ^z   Casson, Peter ^aa   Cataldo, Nicholas A ^u   Christman, Gregory ^ab   Coutifaris, Christos ^v   Diamond, Michael P ^ac   Eisenberg, Esther ^ad   Gosman, Gabriella G ^ae   Giudice, Linda C ^af   Haisenleder, Daniel J ^ag   Huang, Hao ^ah   Krawetz, Stephen A ^ac   Lucidi, Scott ^ai   McGovern, Peter G ^aj   Myers, Evan R ^t   Nestler, John E ^ai   Ohl, Dana ^ab   Santoro, Nanette ^s   Schlaff, William D ^s   Snyder, Peter ^v   Steinkampf, Michael P ^w   Trussell, J C ^ak   Usadi, Rebecca ^al   Yan, Qingshang ^ah   Zhang, Heping ^ah   more..

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF WARWICK   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g CHURCHILL HOSPITAL   (United Kingdom)

^h HAMMERSMITH HOSPITAL   (United Kingdom)

ⁱ BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^j UNIVERSITY OF UTAH   (United States)

^k UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^l ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^m CEDARS SINAI MEDICAL CENTER   (United States)

ⁿ MEDICAL COLLEGE OF GEORGIA   (United States)

^o MEDICAL COLLEGE OF WISCONSIN   (United States)

^p SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^q KAROLINSKA INSTITUTE   (Sweden)

^r PENN STATE COLLEGE OF MEDICINE   (United States)

^s UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^t DUKE UNIVERSITY MEDICAL CENTER   (United States)

^u STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^v UNIVERSITY OF PENNSYLVANIA   (United States)

^w UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^x UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^y UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^z BAYLOR COLLEGE OF MEDICINE   (United States)

^aa UNIVERSITY OF VERMONT   (United States)

^ab UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^ac WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ad EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^ae UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^af UNIVERSITY OF CALIFORNIA   (United States)

^ag UNIVERSITY OF VIRGINIA   (United States)

^ah YALE UNIVERSITY   (United States)

^ai VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aj RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^ak SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^al CAROLINAS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA GLYCOSYLTRANSFERASE; FANCONI ANEMIA GROUP C PROTEIN; FOLLITROPIN BETA SUBUNIT; GONADOTROPIN; LUTEINIZING HORMONE; NEI ENDONUCLEASE VIII LIKE 2; TRANSCRIPTION FACTOR GATA 4; UNCLASSIFIED DRUG;

ANCESTRY; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC ANALYSIS; GENOME; MOLECULAR ANALYSIS; POPULATION STRUCTURE; PROTEIN; SECRETION;

ADOLESCENT; ADULT; ANCESTRY GROUP; ARTICLE; CHROMOSOME 11P; CHROMOSOME 8P; CHROMOSOME 9Q; CONTROLLED STUDY; EUROPEAN; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GONADOTROPIN RELEASE; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CAUCASIAN; GENE EXPRESSION REGULATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MIDDLE AGED; QUANTITATIVE TRAIT LOCUS; YOUNG ADULT;

EUROPE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; YOUNG ADULT;

EID: 84939644572     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-020-15793-w     Document Type: Erratum

References (69)

1. Diamanti-Kandarakis, E. & Dunaif, A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33, 981-1030 (2012).
2. Franks, S., Stark, J. & Hardy, K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum. Reprod. Update 14, 367-378 (2008).
3. Eagleson, C. A. et al. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J. Clin. Endocrinol. Metab. 85, 4047-4052 (2000).
4. Abbott, D. H., Dumesic, D. A. & Franks, S. Developmental origin of polycystic ovary syndrome - a hypothesis. J. Endocrinol. 174, 1-5 (2002).
5. Johnstone, E. B. et al. The polycystic ovary post-Rotterdam: a common, agedependent finding in ovulatory women without metabolic significance. J. Clin. Endocrinol. Metab. 95, 4965-4972 (2010).
6. Fauser, B. C., Diedrich, K. & Devroey, P. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum. Reprod. Update 14, 1-14 (2008).
7. Rotterdam ESHRE ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81, 19-25 (2004).
8. Azziz, R. et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J. Clin. Endocrinol. Metab. 91, 4237-4245 (2006).
9. Fauser, B. C. et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil. Steril. 97, 28-38.e25 (2012).
10. Legro, R. S., Driscoll, D., Strauss, 3rd J. F., Fox, J. & Dunaif, A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc. Natl Acad. Sci. USA 95, 14956-14960 (1998).
11. Franks, S. et al. Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries. J. Clin. Endocrinol. Metab. 93, 3396-3402 (2008).
12. Vink, J. M., Sadrzadeh, S., Lambalk, C. B. & Boomsma, D. I. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J. Clin. Endocrinol. Metab. 91, 2100-2104 (2006).
13. Urbanek, M., Sam, S., Legro, R. S. & Dunaif, A. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J. Clin. Endocrinol. Metab. 92, 4191-4198 (2007).
14. Chen, Z. J. et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat. Genet. 43, 55-59 (2011).
15. Shi, Y. et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat. Genet. 44, 1020-1025 (2012).
16. Lee, H. et al. Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome. Hum. Reprod. 30, 723-731 (2015).
17. Cui, L. et al. Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women. Hum. Reprod. 28, 538-544 (2013).
18. Risch, N. J. Searching for genetic determinants in the new millennium. Nature 405, 847-856 (2000).
19. Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197-206 (2015).
20. Watkins, P. C. et al. DNA sequence and regional assignment of the human follicle-stimulating hormone beta-subunit gene to the short arm of human chromosome. DNA 6, 205-212 (1987).
21. Albanese, C. et al. The gonadotropin genes: evolution of distinct mechanisms for hormonal control. Recent Prog. Horm. Res. 51, 23-58 discussion 59-61 (1996).
22. Rebar, R. et al. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J. Clin. Invest. 57, 1320-1329 (1976).
23. Tuttelmann, F. et al. Combined effects of the variants FSHB -211G4T and FSHR 2039A4G on male reproductive parameters. J. Clin. Endocrinol. Metab. 97, 3639-3647 (2012).
24. Paul, P. et al. A Genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation. Cell 145, 268-283 (2011).
25. LaVoie, H. A. The GATA-keepers of ovarian development and folliculogenesis. Biol. Reprod. 91, 38 (2014).
26. Sander, V. A. et al. Alterations of folliculogenesis in women with polycystic ovary syndrome. J. Steroid Biochem. Mol. Biol. 124, 58-64 (2011).
27. Wood, J. R., Ho, C. K. M., Nelson-Degrave, V. L., McAllister, J. M. & Strauss, J. F. The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling. J. Reprod. Immunol. 63, 51-60 (2004).
28. Bandaru, V., Sunkara, S., Wallace, S. S. & Bond, J. P. A novel human DNA glycosylase that removes oxidative DNA damage and is homologous to Escherichia coli endonuclease VIII. DNA Repair 1, 517-529 (2002).
29. Chalasani, N. et al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease. Gastroenterology 139, 1567-1576 (2010).
30. Diaz-Perales, A. et al. Identification of human aminopeptidase O, a novel metalloprotease with structural similarity to aminopeptidase B and leukotriene A4 hydrolase. J. Biol. Chem. 280, 14310-14317 (2005).
31. Huang, F. et al. The Fanconi anemia group C protein interacts with uncoordinated 5A and delays apoptosis. PLoS ONE 9, e92811 (2014).
32. Ding, L., Traer, E., McIntyre, T. M., Zimmerman, G. A. & Prescott, S. M. The cloning and characterization of a novel human diacylglycerol kinase, DGKiota. J. Biol. Chem. 273, 32746-32752 (1998).
33. Baldinu, P. et al. Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer. Hum. Mutat. 23, 318-326 (2004).
34. Ohlsson, C. et al. Genetic determinants of serum testosterone concentrations in men. PLoS Genet. 7, e1002313 (2011).
35. Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747-753 (2009).
36. Welt, C. K. et al. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J. Clin. Endocrinol. Metab. 97, E1342-E1347 (2012).
37. Mutharasan, P. et al. Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J. Clin. Endocrinol. Metab. 98, E185-E190 (2013).
38. Goodarzi, M. O. et al. Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J. Med. Genet. 49, 90-95 (2012).
39. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76-82 (2011).
40. Ombrello, M. J., Sikora, K. A. & Kastner, D. L. Genetics, genomics, and their relevance to pathology and therapy. Best Pract. Res. Clin. Rheumatol. 28, 175-189 (2014).
41. Costa, V., Aprile, M., Esposito, R. & Ciccodicola, A. RNA-Seq and human complex diseases: recent accomplishments and future perspectives. Eur. J. Hum. Genet. 21, 134-142 (2013).
42. Legro, R. S. et al. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype. J. Clin. Endocrinol. Metab. 90, 2571-2579 (2005).
43. Diamanti-Kandarakis, E. & Panidis, D. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin. Endocrinol. 67, 735-742 (2007).
44. Hirschhorn, J. N. Genomewide association studies-illuminating biologic pathways. N. Engl. J. Med. 360, 1699-1701 (2009).
45. Li, H. & Durbin, R. Inference of human population history from individual whole-genome sequences. Nature 475, 493-496 (2011).
46. Gronau, I., Hubisz, M. J., Gulko, B., Danko, C. G. & Siepel, A. Bayesian inference of ancient human demography from individual genome sequences. Nat. Genet. 43, 1031-1034 (2011).
47. Azziz, R., Dumesic, D. A. & Goodarzi, M. O. Polycystic ovary syndrome: an ancient disorder? Fertil. Steril. 95, 1544-1548 (2011).
48. McCarty, C. A. et al. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med. Genomics 4, 13 (2011).
49. Legro, R. S. et al. The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil. Steril. 86, 914-933 (2006).
50. Legro, R. S. et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N. Engl. J. Med. 371, 119-129 (2014).
51. Kissebah, A. H. et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc. Natl Acad. Sci. USA 97, 14478-14483 (2000).
52. Torchen, L. C., Fogel, N. R., Brickman, W. J., Paparodis, R. & Dunaif, A. Persistent apparent pancreatic beta-cell defects in premenarchal PCOS relatives. J. Clin. Endocrinol. Metab. 99, 3855-3862 (2014).
53. Knochenhauer, E. S. et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J. Clin. Endocrinol. Metab. 83, 3078-3082 (1998).
54. Salameh, W. A. et al. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria. Fertil. Steril. 101, 1135-1141.e2 (2014).
55. Diamanti-Kandarakis, E. et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J. Clin. Endocrinol. Metab. 84, 4006-4011 (1999).
56. Rosenfield, R. L., Mortensen, M., Wroblewski, K., Littlejohn, E. & Ehrmann, D. A. Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test. Hum. Reprod. 26, 3138-3146 (2011).
57. Laurie, C. C. et al. Quality control and quality assurance in genotypic data for genome-wide association studies. Genet. Epidemiol. 34, 591-602 (2010).
58. Turner, S. et al. Quality control procedures for genome-wide association studies. Curr. Protoc. Hum. Genet. Chapter 1, Unit1-19 (2011).
59. Zuvich, R. L. et al. Pitfalls of merging GWAS data: lessons learned in the eMERGE network and quality control procedures to maintain high data quality. Genet. Epidemiol. 35, 887-898 (2011).
60. Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
61. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
62. deBakker, P. I. et al. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum. Mol. Genet. 17, R122-R128 (2008).
63. Browning, B. L. & Browning, S. R. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am. J. Hum. Genet. 84, 210-223 (2009).
64. Frazer, K. A. et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851-861 (2007).
65. Delaneau, O., Marchini, J. & Zagury, J. F. A linear complexity phasing method for thousands of genomes. Nat. Methods 9, 179-181 (2012).
66. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906-913 (2007).
67. Aulchenko, Y. S., Struchalin, M. V. & van Duijn, C. M. ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics 11, 134 (2010).
68. Voight, B. F. et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet. 8, e1002793 (2012).
69. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 26, 2190-2191 (2010).